These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18338279)

  • 1. Greater occipital nevre block in migraine headache: preliminary results of 10 patients.
    Takmaz SA; Inan N; Uçler S; Yazar MA; Inan L; Başar H
    Agri; 2008 Jan; 20(1):47-50. PubMed ID: 18338279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the greater occipital nerve block in recurrent migraine type headaches.
    Okmen K; Dagistan Y; Dagistan E; Kaplan N; Cancan E
    Neurol Neurochir Pol; 2016; 50(3):151-4. PubMed ID: 27154440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater occipital nerve block in chronic migraine.
    Saracco MG; Valfrè W; Cavallini M; Aguggia M
    Neurol Sci; 2010 Jun; 31 Suppl 1():S179-80. PubMed ID: 20464617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial.
    Cuadrado ML; Aledo-Serrano Á; Navarro P; López-Ruiz P; Fernández-de-Las-Peñas C; González-Suárez I; Orviz A; Fernández-Pérez C
    Cephalalgia; 2017 Aug; 37(9):864-872. PubMed ID: 27296456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C2/C3 nerve blocks and greater occipital nerve block in cervicogenic headache treatment.
    Inan N; Ceyhan A; Inan L; Kavaklioglu O; Alptekin A; Unal N
    Funct Neurol; 2001; 16(3):239-43. PubMed ID: 11769869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occipital nerve blockade for cervicogenic headache: a double-blind randomized controlled clinical trial.
    Naja ZM; El-Rajab M; Al-Tannir MA; Ziade FM; Tawfik OM
    Pain Pract; 2006 Jun; 6(2):89-95. PubMed ID: 17309715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the clinical efficacy of GON block at the C2 level and GON block at the classical distal occipital level in the treatment of migraine.
    Karaoğlan M; İnan LE
    Clin Neurol Neurosurg; 2022 Apr; 215():107190. PubMed ID: 35286995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clinical efficacy of ultrasound-guided GON blockade using low and high concentrations of bupivacaine in chronic migraine.
    Parpucu ÜM; Küçük O; Sağ F; Takmaz SA; Kiran B; Durmuş İE; Karaduman Y; Aydemir S
    Turk J Med Sci; 2024; 54(1):213-219. PubMed ID: 38812648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients?
    Ünal-Artık HA; İnan LE; Ataç-Uçar C; Yoldaş TK
    Neurol Sci; 2017 Jun; 38(6):949-954. PubMed ID: 28247118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study.
    Inan LE; Inan N; Karadaş Ö; Gül HL; Erdemoğlu AK; Türkel Y; Akyol A
    Acta Neurol Scand; 2015 Oct; 132(4):270-7. PubMed ID: 25765043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine.
    Ashkenazi A; Young WB
    Headache; 2005 Apr; 45(4):350-4. PubMed ID: 15836572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anesthetic blockade of the greater occipital nerve in migraine prophylaxis].
    Piovesan EJ; Werneck LC; Kowacs PA; Tatsui CE; Lange MC; Vincent M
    Arq Neuropsiquiatr; 2001 Sep; 59(3-A):545-51. PubMed ID: 11588633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study.
    Gul HL; Ozon AO; Karadas O; Koc G; Inan LE
    Acta Neurol Scand; 2017 Aug; 136(2):138-144. PubMed ID: 27910088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients.
    Ercan M; Ertekin A
    Ir J Med Sci; 2024 Aug; 193(4):2001-2009. PubMed ID: 38451438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The results of greater occipital nerve block applied for migraine headache].
    Çatav S; Alkaya Solmaz F; Kırdemir P
    Agri; 2017 Jan; 29(1):33-37. PubMed ID: 28467567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
    Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D
    Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater occipital nerve block for the acute treatment of prolonged or persistent migraine aura.
    Cuadrado ML; Aledo-Serrano Á; López-Ruiz P; Gutiérrez-Viedma Á; Fernández C; Orviz A; Arias JA
    Cephalalgia; 2017 Jul; 37(8):812-818. PubMed ID: 27288355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.